pLVCT-tTR-KRAB Citations (17)
Originally described in: A versatile tool for conditional gene expression and knockdown.Szulc J, Wiznerowicz M, Sauvain MO, Trono D, Aebischer P Nat Methods. 2006 Feb . 3(2):109-16. PubMed Journal
Articles Citing pLVCT-tTR-KRAB
| Articles |
|---|
| Cre recombination-mediated cassette exchange for building versatile transgenic human embryonic stem cells lines. Du ZW, Hu BY, Ayala M, Sauer B, Zhang SC. Stem Cells. 2009 May . 27(5):1032-41. PubMed |
p110 CUX1 homeodomain protein stimulates cell migration and invasion in part through a regulatory cascade culminating in the repression of E-cadherin and occludin.
Kedinger V, Sansregret L, Harada R, Vadnais C, Cadieux C, Fathers K, Park M, Nepveu A.
J Biol Chem. 2009 Oct 2;284(40):27701-11. doi: 10.1074/jbc.M109.031849. Epub 2009 Jul 27.
PubMed
Associated Plasmids |
| Mouse mammary tumor virus p75 and p110 CUX1 transgenic mice develop mammary tumors of various histologic types. Cadieux C, Kedinger V, Yao L, Vadnais C, Drossos M, Paquet M, Nepveu A. Cancer Res. 2009 Sep 15;69(18):7188-97. doi: 10.1158/0008-5472.CAN-08-4899. Epub 2009 Sep 8. PubMed |
| Multipurpose modular lentiviral vectors for RNA interference and transgene expression. Kesireddy V, van der Ven PF, Furst DO. Mol Biol Rep. 2010 Jul;37(6):2863-70. doi: 10.1007/s11033-009-9840-8. Epub 2009 Oct 2. PubMed |
| Lentiviral vector-mediated transgenesis in human embryonic stem cells. Du ZW, Zhang SC. Methods Mol Biol. 2010;614:127-34. doi: 10.1007/978-1-60761-533-0_8. PubMed |
| Inducible transgenic mouse models. Saunders TL. Methods Mol Biol. 2011;693:103-15. doi: 10.1007/978-1-60761-974-1_7. PubMed |
| miR-200 and miR-96 families repress neural induction from human embryonic stem cells. Du ZW, Ma LX, Phillips C, Zhang SC. Development. 2013 Jun;140(12):2611-8. doi: 10.1242/dev.092809. Epub 2013 May 1. PubMed |
| An adaptable system for improving transposon-based gene expression in vivo via transient transgene repression. Doherty JE, Woodard LE, Bear AS, Foster AE, Wilson MH. FASEB J. 2013 Sep;27(9):3753-62. doi: 10.1096/fj.13-232090. Epub 2013 Jun 10. PubMed |
| StUbEx: Stable tagged ubiquitin exchange system for the global investigation of cellular ubiquitination. Akimov V, Henningsen J, Hallenborg P, Rigbolt KT, Jensen SS, Nielsen MM, Kratchmarova I, Blagoev B. J Proteome Res. 2014 Sep 5;13(9):4192-204. doi: 10.1021/pr500549h. Epub 2014 Aug 15. PubMed |
| MYCN-dependent expression of sulfatase-2 regulates neuroblastoma cell survival. Solari V, Borriello L, Turcatel G, Shimada H, Sposto R, Fernandez GE, Asgharzadeh S, Yates EA, Turnbull JE, DeClerck YA. Cancer Res. 2014 Nov 1;74(21):5999-6009. doi: 10.1158/0008-5472.CAN-13-2513. Epub 2014 Aug 27. PubMed |
| Autonomous stimulation of cancer cell plasticity by the human NKG2D lymphocyte receptor coexpressed with its ligands on cancer cells. Cai X, Dai Z, Reeves RS, Caballero-Benitez A, Duran KL, Delrow JJ, Porter PL, Spies T, Groh V. PLoS One. 2014 Oct 7;9(10):e108942. doi: 10.1371/journal.pone.0108942. eCollection 2014. PubMed |
| OTX2 is a therapeutic target for retinoblastoma and may function as a common factor between C-MYC, CRX, and phosphorylated RB pathways. Li J, Di C, Jing J, Di Q, Nakhla J, Adamson DC. Int J Oncol. 2015 Nov;47(5):1703-10. doi: 10.3892/ijo.2015.3179. Epub 2015 Sep 23. PubMed |
| HDAC1/2-Dependent P0 Expression Maintains Paranodal and Nodal Integrity Independently of Myelin Stability through Interactions with Neurofascins. Brugger V, Engler S, Pereira JA, Ruff S, Horn M, Welzl H, Munger E, Vaquie A, Sidiropoulos PN, Egger B, Yotovski P, Filgueira L, Somandin C, Luhmann TC, D'Antonio M, Yamaguchi T, Matthias P, Suter U, Jacob C. PLoS Biol. 2015 Sep 25;13(9):e1002258. doi: 10.1371/journal.pbio.1002258. eCollection 2015. PubMed |
Probing the impact of chromatin conformation on genome editing tools.
Chen X, Rinsma M, Janssen JM, Liu J, Maggio I, Goncalves MA.
Nucleic Acids Res. 2016 Jun 8. pii: gkw524.
PubMed
Associated Plasmids |
| StUbEx PLUS-A Modified Stable Tagged Ubiquitin Exchange System for Peptide Level Purification and In-Depth Mapping of Ubiquitination Sites. Akimov V, Olsen LCB, Hansen SVF, Barrio-Hernandez I, Puglia M, Jensen SS, Solov'yov IA, Kratchmarova I, Blagoev B. J Proteome Res. 2018 Jan 5;17(1):296-304. doi: 10.1021/acs.jproteome.7b00566. Epub 2017 Nov 1. PubMed |
| Overexpression of Nuclear Receptor 5A1 Induces and Maintains an Intermediate State of Conversion between Primed and Naive Pluripotency. Yamauchi K, Ikeda T, Hosokawa M, Nakatsuji N, Kawase E, Chuma S, Hasegawa K, Suemori H. Stem Cell Reports. 2020 Mar 10;14(3):506-519. doi: 10.1016/j.stemcr.2020.01.012. Epub 2020 Feb 20. PubMed |
| Targeting CLK3 inhibits the progression of cholangiocarcinoma by reprogramming nucleotide metabolism. Zhou Q, Lin M, Feng X, Ma F, Zhu Y, Liu X, Qu C, Sui H, Sun B, Zhu A, Zhang H, Huang H, Gao Z, Zhao Y, Sun J, Bai Y, Jin J, Hong X, Zou C, Zhang Z. J Exp Med. 2020 Aug 3;217(8). pii: 151816. doi: 10.1084/jem.20191779. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.